4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-17-065442
Director gave up 13,094 shares (to pay taxes)
- Director acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CANNON JAMES ANTHONY Director | 2017-12-12 | Option exercise | +20,000 | $2.73 | $54,600 | 387,502 | D |
| CANNON JAMES ANTHONY Director | 2017-12-12 | Shares withheld for taxes | −13,094 | $4.17 | $54,602 | 374,408 | D |
| Derivatives | |||||||
| CANNON JAMES ANTHONY Director | 2017-12-12 | Option exercise · Stock Option (right to buy) | −20,000 | 0 | D | ||
Loading xslF345X03/doc4.xml…